基于CRISPR/Cas与Argonaute核酸酶的病毒检测技术
本综述介绍了CRISPR/Cas(Cas9、Cas12、Cas13)与Argonaute系统的机制与功能,并回顾其在单重与多重病毒检测中的应用;这些方法可在1小时内达到阿摩尔级灵敏度或单拷贝检测限,且无需复杂昂贵仪器。文中还讨论了PAM序列要求、核酸提取扩增耗时及核心组分稳定性等挑战,并展望提升特异性、多重能力与POCT的发展方向。
要点
- CRISPR/Cas与Argonaute检测可达阿摩尔级或单拷贝灵敏度,1小时内完成且无需复杂仪器。
- 多重检测平台包括MiCaR(30重)、PAND(5重)、SHERLOCKv2(4重)和CARMEN(>100靶标)。
- 主要挑战包括Cas9/12的PAM序列要求、提取扩增耗时及核酸酶与crRNA的不稳定性。
核心结论
- 基于CRISPR/Cas与Argonaute的检测方法有望变革分子诊断,实现全球可及、精准鉴定与传染病传播的战略遏制。
研究设计与样本
- 本文为综述,首先介绍CRISPR/Cas系统(Cas9、Cas12、Cas13)与Argonaute系统的机制和功能,继而回顾其在单重与多重病毒检测中的应用,最后讨论挑战与未来方向。
主要发现
- 单重病毒检测包括利用Cas9反式切割活性的DACD/RACD、基于Cas12的DETECTR(阿摩尔级灵敏度)、基于Cas13a的CFNS(1 copy/mL灵敏度,量子点报告)、以及无需扩增的手机检测(31 copies/μL)。
- 多重病毒检测包括MiCaR(微流控芯片空间区分实现30重)、PAND(Ago产引导序列实现5重)、SHERLOCKv2(多酶单反应体系实现4重)和CARMEN(支持超过100靶标检测)。
关键数值与推荐
- CRISPR/Cas与Argonaute检测方法可在1小时内达到阿摩尔级灵敏度或单拷贝检测限,并具有单碱基特异性,无需复杂或昂贵仪器。
临床怎么用
- 此类检测工具操作简便、无需复杂仪器,有望在资源有限场景实现病毒精准鉴定与传播遏制。
局限性
- Cas9/12存在PAM序列要求,核酸提取与扩增导致反应时间延长,核酸酶和crRNA等核心组分不稳定,检测特异性与多重能力仍需进一步提升。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Viral pandemics pose severe threats to human health and societal stability, exemplified by the COVID-19 outbreak in 2019. Conventional viral detection methods such as Polymerase chain reaction (PCR) typically require trained personnel, expensive equipment, and 2-4 h for processing. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) and Argonaute (Ago) system-based detection methods achieve attomolar sensitivity or single-copy detection limits with single-base specificity within 1 h, without requiring complex or costly instruments. This review firstly introduces the mechanisms and functions of CRISPR/Cas systems (Cas9, Cas12, Cas13) and Ago systems. It also introduces viruses with significant social impact, and continued with reviewing applications of these systems in single and multiplex virus detection. Single viral detection includes recently developed DNA/RNA-activated Cas9 detection (DACD/RACD) using Cas9 trans-cleavage activity, Cas12-based DNA Endonuclease-targeted CRISPR Trans Reporter (DETECTR) with attomolar sensitivity, CRISPR/Cas13a-based Fluorescent Nanoparticle SARS-CoV-2 (CFNS) achieving 1 copy/mL sensitivity with quantum dot reporters, and amplification-free mobile phone detection detecting 31 copies/μL without amplification. Multiplex viral detection includes Microfluidic Device Integrated with CRISPR/Cas12a and Multiplex Recombinase Polymerase Amplification (MiCaR) enabling 30-plex detection through microfluidic chips with spatial discrimination, PfAgo-mediated Nucleic acid Detection (PAND) utilizing Ago-produced guide sequences for 5-plex detection, Specific High-Sensitivity Enzymatic Reporter UnLOCKing v2 (SHERLOCKv2) achieving 4-plex detection with multi-enzyme single-reaction systems, and Multiplexed Evaluation of Nucleic acids (CARMEN) supporting over 100 target assays. Finally, this review discusses challenges in CRISPR/Cas and Ago-based detection methods, including Protospacer Adjacent Motif (PAM) sequence requirements for Cas9/12, prolonged reaction times due to nucleic acid extraction/amplification, and instability of core components like nucleases and crRNAs. Detection specificity and multiplex capabilities could be further improved. Future directions are outlined for improving detection specificity, developing multiplex capabilities and advancing POCT. Developing diagnostic tools using CRISPR/Cas and Ago systems could transform molecular diagnostics, such tools promise to be easily accessible worldwide. They are essential for precise identification and strategic containment of infectious disease transmission.
引用
- Xu L, Wu X. Viral detection using Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein and Argonaute nucleases. Clin Chim Acta. 2025. PMID: 40763823. doi:10.1016/j.cca.2025.120526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。